Furthermore, it has known that BMI1 negatively regulates expression of p16/INK4A [6], and as such, we observed an increase in p16 protein expression in all three canine OSA cell lines following PTC-209 inhibition of BMI1. The gene discussed is CDKN2A; the disease is obstructive sleep apnea syndrome.